| Feature | No.43 January 2005 |
Press Release: WADA Executive Committee approves the 2005 Prohibited List |
Montreal, September 21, 2004 – The World Anti-Doping Agency (WADA) announced today that its Executive Committee approved the Prohibited List of Substances and Methods for 2005. The new List will will go into effect January 1, 2005. Some changes will be made from the current List in 2005. For example, the topical application of glucocorticosteroids will no longer require an abbreviated therapeutic use exemption. Beta-2 agonists, often used in the treatment of asthma, will now be prohibited both in and out of competition. Due to the findings of a WADA-sponsored research project, Finasteride, a product used for prostate problems in men and also for hair loss, will be added to the Prohibited List as a masking agent. Finally, intravenous infusion for non-medical purposes will now be explicitly banned. The Executive Committee based its decisions regarding the List on the recommendations of WADA’s List Committee and Health-Medical and Research Committee, which met in September to discuss the 2005 List. Since 2004, WADA has been tasked with issuing the List on an annual basis, a responsibility previously held by the International Olympic Committee (IOC). A substance or method is added to the List if it meets two of three criteria: it is performance enhancing, poses a danger to athletes’ health, and its use is against the spirit of sport. “Refining the List is an important part of WADA’s responsibilities under the World Anti-Doping Code,” said Richard W. Pound, WADA’s president. “The changes we have made this year reflect our expanding scientific knowledge and our ability to better identify performance enhancing substances and methods.” http://list.wada-ama.org/t/12094/41001/114/0/ - to view the Press Release http://www.wada-ama.org/en/t2.asp?p=42240 – to view the World Anti-Doping Code http://www.icsspe.org/portal/bulletin-january2005.htm Press Release: WADA Executive Committee approves the 2005 Prohibited List